Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,506.48
(
-1.51%
)
US TECH 100
23,042.40
(
-1.03%
)
Dow Jones
45,577.47
(
-0.96%
)
Brent Oil
98.94
(
-8.50%
)
Bitcoin
70,692.01
(
4.21%
)
News Focus
News Focus
Post# of 257269
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next

semi_infinite

Send PM Follow Ignore
Followers 15
Posts 4014
Boards Moderated 1
Alias Born 07/07/2002

semi_infinite

Re: semi_infinite post# 221758

Thursday, 01/17/2019 11:42:20 AM

Thursday, January 17, 2019 11:42:20 AM

Post# of 257269
EYPT/OCUL - eypt moved up their launch date for post cataract surgery anti-inflammatory behind the iris insert (placed as part of cataract procedure) to Q1 from Q2. Ocul has a less invasive insert that goes into the tear duct area (cleared in December and has not announced launch timing). Both are sustain-release steroids that last 30 days. Any thoughts or comments on market share? Current SOC is 30 days of eye drops.
Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today